No one would argue that MSB hasn’t spent a lot of capital, that isn’t the point and doesn’t really answer my question. I am interested in whether they are at a stalemate while trying to resolve the potency issues or whether trials are allowed to move forward in tandem. Obviously the timeline is a concern given the cash balance.
disclosure - I held MSB a few years ago (before COVID) and sold for a healthy profit, holding through phase 3 trial results didn’t suit my risk appetite.
replying to @Sector above
- Forums
- ASX - By Stock
- MSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-53
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.08 |
Change
0.048(4.61%) |
Mkt cap ! $1.230B |
Open | High | Low | Value | Volume |
$1.05 | $1.09 | $1.03 | $4.138M | 3.878M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 25677 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 48262 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 18508 | 1.075 |
23 | 44694 | 1.070 |
8 | 36051 | 1.065 |
9 | 37713 | 1.060 |
3 | 23555 | 1.055 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 50253 | 16 |
1.085 | 123599 | 15 |
1.090 | 224479 | 11 |
1.095 | 108131 | 10 |
1.100 | 248633 | 23 |
Last trade - 13.10pm 02/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |